glp-1 receptor agonist and dpp-4 inhibitor combination not recommended Comparison of agonists inhibitors Insights into the Roles of
Description
Madamanchi A -Adrenergic receptor signaling in cardiac function and heart failure

2018;72:e13055

doi: 10.1007/s40265-014-0321-6 183 ChalasaniNYounossiZLavineJECharltonMCusiKRinellaMet al

Diarrhea affects about 30% of users of both medications

Friedrichsen M, Breitschaft A, Tadayon S, et al
Even among patients with diabetes, where the clinical case for continued treatment was strongest, 46.5 percent stopped within 12 months
